The investment objective of the scheme is to provide returns that correspond to the total returns of the securities as represented by the underlying index, subject to tracking error.
Expert-managed portfolios tailored to your financial goals and risk appetite.
| Index Funds | 1M | 3M | 6M | 9M | 1Y | 2Y | 3Y | 4Y | 5Y | 10Y | ALL |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund returns | -4.63% | -6.5% | -4.03% | -8.26% | -13.48% | N/A | N/A | N/A | N/A | N/A | -2.76% |
| Category returns | -3.49% | -4.55% | -2.01% | -3.44% | -4% | -2.79% | 10.35% | 12.84% | 9.89% | 11.22% | N/A |
| Absolute returns | -4.63% | -6.5% | -4.03% | -8.26% | -13.48% | N/A | N/A | N/A | N/A | N/A | -5.37% |
| Rank within category | 125/216 | 167/207 | 130/199 | 159/193 | 175/184 | N/A | N/A | N/A | N/A | N/A | N/A |
| Index Funds | 2024 | 2025 | 2026 |
|---|---|---|---|
| Yearly returns | N/A | 8.26% | -11.03% |
| Q1 returns | N/A | -5.69% | -16.03% |
| Q2 returns | N/A | 10.64% | 11.39% |
| Q3 returns | N/A | 2.01% | -3.68% |
| Q4 returns | N/A | 1.7% | -1.25% |
0.25% on or before 15D, Nil after 15D
| Alpha | -0.0825302 |
| Beta | 0.999 |
| Sharpe Ratio | -0.12266 |
| Sortino Ratio | -0.201545 |
| R-Squared | 0.9955 |
| Tracking Error | 0.0723 |
| Downside Risk | 20.1715 |
| Std. Deviation (Annualised) | 14.467 |
| Index Funds | 1M | 3M | 6M | 9M | 1Y | 3Y | 5Y | 10Y | ALL | Fund Size (Cr) | Exp. Ratio | Sharpe | Risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICICI Prudential NASDAQ 100 Index Fund - Growth | -1.52% | 1.37% | 12.73% | 20.33% | 27.46% | 30.85% | 18.72% | N/A | 18.87% | 3,738.17 | 1.06 | 0.39 | Very High |
| Motilal Oswal S&P 500 Index Fund - Regular Plan - Growth | -0.5% | 1.6% | 10.19% | 15.5% | 24.15% | 26.62% | 16.54% | N/A | 19.94% | 4,584.30 | 1.04 | 0.44 | Very High |
| ICICI Prudential Nifty Pharma Index Fund - Regular Plan - Growth | -4.18% | -0.29% | 13.6% | 15.38% | 14.48% | 18.13% | N/A | N/A | 18.71% | 163.10 | 1.18 | 0.29 | Very High |
| UTI Nifty 500 Value 50 Index Fund - Regular Plan - Growth | -4.93% | -6.29% | -9.73% | -4.85% | 2.97% | 18.1% | N/A | N/A | 23.08% | 838.01 | 1.21 | 0.22 | Very High |
| Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund - Regular Plan - Growth | -4.3% | -1.59% | 11.56% | 11.09% | 13.2% | 17.83% | 12.7% | N/A | 14.93% | 191.85 | 1.10 | 0.32 | Very High |
| Motilal Oswal BSE Enhanced Value Index Fund - Regular Plan - Growth | -3.42% | -6.2% | -9.67% | -9.99% | -0.86% | 17.49% | N/A | N/A | 24.9% | 2,131.66 | 1.12 | 0.19 | Very High |
| Aditya Birla Sun Life Nifty Smallcap 50 Index Fund - Regular Plan - Growth | -4.83% | -1.02% | 10.76% | 12.27% | 8.48% | 15.62% | 10.2% | N/A | 15.72% | 364.19 | 1.11 | 0.18 | Very High |
| Kotak Nifty Smallcap 50 Index Fund - Regular Plan - Growth | -5.01% | -1.19% | 10.63% | 11.86% | 8.08% | 15.42% | N/A | N/A | 24.48% | 259.53 | 0.92 | 0.18 | Very High |
| ICICI Prudential Nifty Auto Index Fund - Regular Plan - Growth | -5.75% | -5.5% | -2.85% | -7.06% | -5.92% | 15.29% | N/A | N/A | 19.15% | 234.49 | 0.95 | 0.18 | Very High |
| SBI Nifty India Consumption Index Fund - Regular plan - Growth Current | -4.63% | -6.5% | -4.03% | -8.26% | -13.48% | N/A | N/A | N/A | -2.76% | 239.13 | 0.90 | -0.12 | Very High |
| Name | Sector | Instrument | Assets % |
|---|---|---|---|
| Bharti Airtel Ltd. | Telecom - Services | Domestic Equities | 10.14% |
| Mahindra & Mahindra Ltd. | Automobiles | Domestic Equities | 8.19% |
| ITC Ltd. | Diversified FMCG | Domestic Equities | 7.87% |
| Eternal Ltd. | Retailing | Domestic Equities | 7.21% |
| Titan Company Ltd. | Consumer Durables | Domestic Equities | 5.89% |
| Hindustan Unilever Ltd. | Diversified FMCG | Domestic Equities | 5.18% |
| Maruti Suzuki India Ltd. | Automobiles | Domestic Equities | 4.84% |
| Bajaj Auto Ltd. | Automobiles | Domestic Equities | 3.69% |
| Interglobe Aviation Ltd. | Transport Services | Domestic Equities | 3.51% |
| Asian Paints Ltd. | Consumer Durables | Domestic Equities | 3.37% |
| Eicher Motors Ltd. | Automobiles | Domestic Equities | 3.07% |
| TVS Motor Company Ltd. | Automobiles | Domestic Equities | 3.00% |
| Nestle India Ltd. | Food Products | Domestic Equities | 2.92% |
| Trent Ltd. | Retailing | Domestic Equities | 2.71% |
| Apollo Hospitals Enterprise Ltd. | Healthcare Services | Domestic Equities | 2.61% |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.20% |
| Max Healthcare Institute Ltd. | Healthcare Services | Domestic Equities | 2.15% |
| Hero MotoCorp Ltd. | Automobiles | Domestic Equities | 2.11% |
| The Indian Hotels Company Ltd. | Leisure Services | Domestic Equities | 1.99% |
| Tata Consumer Products Ltd. | Agricultural Food & other Products | Domestic Equities | 1.92% |
| Avenue Supermarts Ltd. | Retailing | Domestic Equities | 1.91% |
| Tata Power Company Ltd. | Power | Domestic Equities | 1.87% |
| Varun Beverages Ltd. | Beverages | Domestic Equities | 1.84% |
| Britannia Industries Ltd. | Food Products | Domestic Equities | 1.77% |
| Dixon Technologies (India) Ltd. | Consumer Durables | Domestic Equities | 1.70% |
| Info Edge (India) Ltd. | Retailing | Domestic Equities | 1.47% |
| DLF Ltd. | Realty | Domestic Equities | 1.34% |
| Fortis Healthcare Ltd. | Healthcare Services | Domestic Equities | 1.25% |
| United Spirits Ltd. | Beverages | Domestic Equities | 1.24% |
| TREPS | Cash & Cash Equivalents and Net Assets | 1.16% | |
| Godrej Consumer Products Ltd. | Personal Products | Domestic Equities | 1.06% |
| Net Receivable / Payable | Cash & Cash Equivalents and Net Assets | -1.17% | |
| Total | 100.00% | ||
Mr. Viral Chhadva (Equity Dealer) joined SBIFML in December 2020. He has over 17 years of experience in financial services sector. Prior to joining SBIFML, he was previously associated with IIFL Securities Limited (June 2008 till December 2020) and ICICI Securities Limited (June 2006 till June 2008) wherein he primarily handled execution of trades into Direct Market Access, Exchange Traded Funds and Derivatives.
Get personalized portfolio management services designed to grow and protect your wealth.
ChatGPT
Claude
Perplexity
